Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/19/2012US20120093947 Method of treating reactive airway disease
04/19/2012US20120093945 Method for treating an inflammation or lesion caused by a virus
04/19/2012US20120093940 Medical food or nutritional supplement for managing blood glucose levels and method of manufacturing same
04/19/2012US20120093939 Oral formulations
04/19/2012US20120093938 Orally disintegrating tablets comprising diphenhydramine
04/19/2012US20120093933 Denatured lactoglobulin and polyphenol coassemblies
04/19/2012US20120093932 Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
04/19/2012US20120093930 Article and method for focused delivery of therapeutic and/or diagnostic materials
04/19/2012US20120093929 Opioid Composition for Treating Skin Lesions
04/19/2012US20120093928 Oral metaxalone compositions
04/19/2012US20120093927 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
04/19/2012US20120093924 Methods of treating hypertriglyceridemia
04/19/2012US20120093923 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses, Or Conditions
04/19/2012US20120093922 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
04/19/2012US20120093918 Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
04/19/2012US20120093917 Metnase and intnase inhibitors and their use in treating cancer
04/19/2012US20120093916 Devices, Systems and Methods for Improving Memory and/or Cognitive Function Through Brain Delivery of SIRNA
04/19/2012US20120093915 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
04/19/2012US20120093914 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone particles as scaffolds for tissue regeneration
04/19/2012US20120093913 Inhibition of SYK kinase expression
04/19/2012US20120093911 Platinum-catalyzed intravaginal rings
04/19/2012US20120093910 Non-hormonal vaginal contraceptive
04/19/2012US20120093898 Metal Ion Nanoclusters
04/19/2012US20120093894 Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
04/19/2012US20120093893 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
04/19/2012US20120093892 Minocycline oral dosage forms for the treatment of acne
04/19/2012US20120093891 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120093890 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
04/19/2012US20120093889 Layered pharmaceutical formulations
04/19/2012US20120093888 micro-emulsions for the treatment of rheumatic disorders
04/19/2012US20120093887 Amorphous varenicline tartrate co-precipitates
04/19/2012US20120093883 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
04/19/2012US20120093882 Stable pharmaceutical compositions of diclofenac
04/19/2012US20120093878 Pharmaceutical compositions containing a biguanide and a thiazolidinedione
04/19/2012US20120093876 Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
04/19/2012US20120093875 Aminocyclitol compounds, process for obtaining them and uses
04/19/2012US20120093874 Method for screening for diet providing production of milk having immunoregulatory action
04/19/2012US20120093863 Hcv vaccines and methods for using the same
04/19/2012US20120093862 Nucleic acid vaccines for prevention of flavivirus infection
04/19/2012US20120093856 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093843 Tem8 peptides and vaccines comprising the same
04/19/2012US20120093838 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy
04/19/2012US20120093837 Compositions and methods for detecting egfr in cancer
04/19/2012US20120093836 Pharmaceutical compositions for treating metastasis
04/19/2012US20120093831 Methods and materials for modulating resistance to apoptosis
04/19/2012US20120093829 New methods for treatment of inflammatory diseases
04/19/2012US20120093828 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
04/19/2012US20120093822 Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
04/19/2012US20120093817 USE OF THE GENES IN THE HOG, Ras AND cAMP PATHWAY FOR TREATMENT OF FUNGAL INFECTION
04/19/2012US20120093816 Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus
04/19/2012US20120093815 Fgf21 mutants and uses thereof
04/19/2012US20120093809 Use of alkanoyl l-carnitine in combination with chemotherapeutic agents for the treatment of neoplasms
04/19/2012US20120093803 Means and methods of sterilization of biofunctional compositions
04/19/2012US20120093802 Bioactive composition including stabilized protein and process for producing the same
04/19/2012US20120093801 Targeted delivery of therapeutic agents with lyophilized matrices
04/19/2012US20120093800 plant extract comprising statins and preparation techniques and uses thereof
04/19/2012US20120093789 Methods of Modulating Smooth Muscle Cell Proliferation and Differentiation
04/19/2012US20120093788 Protease for wound conditioning and skin care
04/19/2012US20120093768 Anti-connexin compounds targeted to connexins and methods of use thereof
04/19/2012US20120093767 Compounds for the Treatment of Hepatitis C
04/19/2012US20120093766 Compounds for the Treatment of Hepatitis C
04/19/2012US20120093763 Rna virus infection inhibitor, method for inhibition of infection by rna virus, rna virus infection-inhibiting product, and use as rna virus infection inhibitor
04/19/2012US20120093761 Vaccine compositions and methods of use thereof
04/19/2012US20120093760 Polyquaternium-1 synthesis methods
04/19/2012US20120093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds
04/19/2012US20120093752 Use of Monoamine Oxidase Inhibitors to Improve Epithelial Biology
04/19/2012US20120093748 Topical personal care and pharmaceutical compositions and uses thereof
04/19/2012US20120093739 Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore
04/19/2012US20120093738 Taste-masked oral formulations of influenza antivirals
04/19/2012US20120093729 Novel phosphorus-containing prodrugs
04/19/2012US20120093728 Mitochondrial inhibitors to treat human disease
04/19/2012US20120093718 Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
04/19/2012US20120091022 Sustained-release formulation for injection
04/19/2012DE102010048883A1 Use of buprenorphine for abuse protection in pharmaceutical compositions containing a opioid full-agonist
04/19/2012DE102010048374A1 Pyrrolidinone als MetAP-2 Inhibitoren Pyrrolidinone as MetAP-2 inhibitors
04/19/2012DE102010042615A1 1:1, 2:1- oder 3:1-Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem halogeniertem Ether, seine Herstellung und seine Verwendung als Schlafmittel 1: 1, 2: 1 or 3: 1 complex consisting of a cyclodextrin or cyclodextrin derivative and a halogenated ether, its preparation and its use as a sleep aid
04/19/2012DE102010014412A1 Use of dinuclear iron complexes having sulfur-containing ligands as carbon monoxide-releasing pharmacological agents e.g. for treating hypertension, cancer, tissue damage by irradiation, post-ischemic injury, atherosclerosis or sepsis
04/19/2012CA2851694A1 Treatment of cancer/inhibition of metastasis
04/19/2012CA2850468A1 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
04/19/2012CA2836248A1 Food supplement
04/19/2012CA2821993A1 Combination treatment for dermatological conditions
04/19/2012CA2814696A1 Pharmaceutical formulation for histone deacetylase inhibitors
04/19/2012CA2814694A1 Methods of treating giardiasis
04/19/2012CA2814688A1 Heteroaryls and uses thereof
04/19/2012CA2814676A1 Use of monoamine oxidase inhibitors to improve epithelial biology
04/19/2012CA2814643A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012CA2814628A1 Acylbenzene derivative
04/19/2012CA2814540A1 Inhibitors of p75 receptor and their uses
04/19/2012CA2814518A1 Compositions and methods of treating pulmonary hypertension
04/19/2012CA2814503A1 Substituted benzamides and their uses
04/19/2012CA2814495A1 Clevidipine emulsion formulations containing antimicrobial agents
04/19/2012CA2814445A1 Pharmaceutical composition
04/19/2012CA2814442A1 Hypocholesterolemic, anti-inflammatory and antiepileptic neuroprotective compound
04/19/2012CA2814419A1 Cxcr4 receptor antagonists
04/19/2012CA2814413A1 Sulphonamide compounds and methods of making and using same
04/19/2012CA2814404A1 Coffee extracts as ingredients of foods, drugs, cosmetics, dietary supplements, and biologics
04/19/2012CA2814369A1 Pyrrolidinones as metap-2 inhibitors
04/19/2012CA2814333A1 Anti-inflammatory macrolides
04/19/2012CA2814194A1 Antitussive compositions comprising memantine
1 ... 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 ... 7860